Forget term deposits! I'd buy these ASX dividend shares instead

Term deposits are not exciting to me because of one key reason.

Following multiple interest rate rises this year, the interest income on offer from term deposits looks appealing. However, I still prefer ASX dividend shares.

Savers can now get term deposit interest rates in the mid-5% range, which challenges the yield on offer from certain ASX dividend stocks.

But, it's not just the income over the next 12 months that I'd look at. It's the passive income beyond that time period that the ASX dividend shares can shine.

Businesses can grow their payouts sustainably if their earnings grow. Term deposit rates are stuck at the same rate (ignoring interest rate changes). Over time, the ASX dividend share can deliver significantly more income.

So, below are two businesses that offer defensive earnings, with payout growth.

Man holding a calculator with Australian dollar notes, symbolising dividends.

Image source: Getty Images

Centuria Industrial REIT (ASX: CIP)

This first business is a real estate investment trust (REIT) that invests in industrial property across Australian cities.

It ticks the box for distribution growth. In FY26, it grew the distribution per unit by 3% and it expects to hike the payout again in FY27 by another 3%.

The business has guided that it expects to pay a distribution per unit of 17.3 cents. That translates into a forward distribution yield of 6.25% – superior to what term deposits are offering today.

I expect the REIT can continue growing its distribution because the outlook for rental income looks so positive.

Following the significant increase of the rental potential of metropolitan industrial land this decade, it's now seeing that boost flow through as new leases are signed.

In the first quarter of FY27, the ASX dividend share reported re-leasing spreads of 31%. That means the new lease earns 31% more rental income than the old lease, which is a significant increase.

The business estimates that the portfolio is 17% under-rented on average, providing a "significant runway for future earnings growth beyond FY27". It can grow earnings without requiring additional balance sheet deployment.

Medibank Private Ltd (ASX: MPL)

Medibank is the largest private health insurer in Australia, with its Medibank and ahm brands. The business is regularly growing its healthcare division with the acquisitions. Investments include certain businesses such as Myhealth Medical and a minority stake in a few hospitals.

Healthcare is generally a defensive industry that can provide resilient earnings and pay consistent dividends. There's also a growth tailwind for the business with Australia's ageing population.

The ASX dividend share's FY26 result was a demonstration of how it can deliver earnings growth and payout growth for shareholders.

It saw net resident policyholder growth of 22,100 (or 1.1%), which helped revenue grow 5.9% to $8.6 billion. Health insurance operating profit rose 3.8% to $769.8 million and Medibank Health segment profit increased 31.3% to $100.7 million. Including corporate overheads, group operating profit grew 6.7% to $813.5 million.

That operating profit helped the dividend per share increase 6.7% to 19.2 cents. That translates into a trailing grossed-up dividend yield of 5.7%, including franking credits.

The forecast on CommSec suggests the business could hike its dividend by 12% to 21.5 cents per share. That'd be a grossed-up dividend yield of 6.3%, including franking credits.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two colleagues looking at a graph and comparing share prices.
Healthcare Shares

Pro Medicus vs Telix Pharmaceuticals: Which is more likely to double your money in 2 years?

Can Pro Medicus or Telix Pharmaceuticals double your money on the ASX? We stack up their value, growth, and price…

Read more »

Happy doctor using her laptop.
Healthcare Shares

CSL has a new CEO. Are its shares a buy?

I look at what the incoming CEO could bring to the business as its recovery continues.

Read more »

A sobbing businessman accused of wrongdoing faces justice
Healthcare Shares

CSL responds to class action, defends disclosure record

The CSL share price is under the microscope after it revealed it will defend a newly filed class action lawsuit.

Read more »

Happy businessman fist pumping while looking at a tablet.
Healthcare Shares

Up 13%: Why is everyone buying Pro Medicus shares this week?

The ASX healthcare shares jumped another 3% on Wednesday.

Read more »

healthcare worker overseeing group of aged care residents at table
Healthcare Shares

Regis Healthcare vs Ryman Healthcare: Which under-the-radar ASX small-cap could double from here?

We compare Regis Healthcare and Ryman Healthcare shares to find out which aged care small-cap could bounce back faster.

Read more »

Smiling female CEO with arms crossed stands in office with co-workers in background.
Healthcare Shares

CSL names Deborah Waterhouse as next CEO in global search

CSL has appointed Deborah Waterhouse as its next CEO, signalling continuity and experience as it moves into its next growth…

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Telix shares crashing 8% today: What happened?

Find out what is going on with the ASX healthcare shares today.

Read more »

An older woman tries to listen by cupping her ear.
Healthcare Shares

Cochlear shares jump 9% in a week: Can they break past $150?

The shares are climbing higher into the green again on Wednesday.

Read more »